References
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 2000.
Chakrabarti S, Fombonne E: Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 2005, 162:1133–1141.
Volkmar F, Cook E Jr, Pomeroy J, et al.: Summary of the practice parameters for the assessment and treatment of children, adolescents and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1999, 38:1611–1616.
Lecavalier L: Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics and empirical classification. J Autism Dev Disord 2006, 36:1101–1114.
Myers SM, Johnson CP: Management of children with autism spectrum disorders. Pediatrics 2007, 120:1162–1182.
Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002, 347:314–321.
Shea S, Turgay A, Carrol A, et al.: Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004, 114:e634-e641.
Valecenti-McDermott MR, Demb H: Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities. J Child Adolesc Psychopharmacol 2006, 16:549–560.
Stigler KA, Posey DJ, McDougle CJ: Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol 2004, 14:455–463.
Owen R, Sikich L, Marcus RN, et al.: Aripiprazole in the treatment of irritability in children and adolescents with autistic disorders. Pediatrics 2009, 124:1533–1540.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benton, T.D. Aripiprazole to Treat Irritability Associated With Autism: A Placebo-Controlled, Fixed-Dose Trial. Curr Psychiatry Rep 13, 77–79 (2011). https://doi.org/10.1007/s11920-010-0172-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11920-010-0172-0